Media Summary: The panel discusses the safety and tolerability of Dermatology experts remark on the impressive results of clinical data supporting the use of newer With multiple drug classes available for plaque

Il 23s Psoriasis Therapy Overview - Detailed Analysis & Overview

The panel discusses the safety and tolerability of Dermatology experts remark on the impressive results of clinical data supporting the use of newer With multiple drug classes available for plaque Host: Raj Chovatiya, MD, PhD Guest: George Han, MD, PhD The discovery of the Interview with Richard G. Langley MD, PhD, on Dr. Laura Korb Ferris, MD, PhD, Professor, University of Pittsburgh Clinical and Translational Science Institute and Director of ...

To cite: Eyerich K, Weisenseel P, Pinter A, et al. January 21st, 2020- 2020 Winter Clinical Dermatology Conference – Hawaii. Interview with Bruce E. Strober MD, PhD, on

Photo Gallery

IL-23s: Psoriasis therapy overview
Safety and Efficacy of IL-23 Inhibitors in Plaque Psoriasis
Efficacy of IL-23 Inhibitors in Plaque Psoriasis
Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors
Psoriasis Treatment Redefined: Exploring the Impact of IL-23 Inhibitors
IL-17 inhibitors and IL-23 inhibitors in psoriasis
New Data Demonstrates Potential for Oral IL-23 in Psoriasis
IL23 & IL12/23 Inhibitors: An Overview
What Are IL-23 Inhibitors For Psoriasis Treatment? - Psoriasis Relief Guide
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis
IL-23 Therapies in the Management of Psoriasis: Alice Gottlieb, MD, PhD & April W Armstrong, MD, MPH
IL-17 and IL-23 inhibitors in the treatment of psoriatic arthritis
Sponsored
Sponsored
View Detailed Profile
IL-23s: Psoriasis therapy overview

IL-23s: Psoriasis therapy overview

People with moderate-to-severe

Safety and Efficacy of IL-23 Inhibitors in Plaque Psoriasis

Safety and Efficacy of IL-23 Inhibitors in Plaque Psoriasis

The panel discusses the safety and tolerability of

Sponsored
Efficacy of IL-23 Inhibitors in Plaque Psoriasis

Efficacy of IL-23 Inhibitors in Plaque Psoriasis

Dermatology experts remark on the impressive results of clinical data supporting the use of newer

Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors

Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors

With multiple drug classes available for plaque

Psoriasis Treatment Redefined: Exploring the Impact of IL-23 Inhibitors

Psoriasis Treatment Redefined: Exploring the Impact of IL-23 Inhibitors

Host: Raj Chovatiya, MD, PhD Guest: George Han, MD, PhD The discovery of the

Sponsored
IL-17 inhibitors and IL-23 inhibitors in psoriasis

IL-17 inhibitors and IL-23 inhibitors in psoriasis

Interview with Richard G. Langley MD, PhD, on

New Data Demonstrates Potential for Oral IL-23 in Psoriasis

New Data Demonstrates Potential for Oral IL-23 in Psoriasis

Dr. Laura Korb Ferris, MD, PhD, Professor, University of Pittsburgh Clinical and Translational Science Institute and Director of ...

IL23 & IL12/23 Inhibitors: An Overview

IL23 & IL12/23 Inhibitors: An Overview

IL23 and

What Are IL-23 Inhibitors For Psoriasis Treatment? - Psoriasis Relief Guide

What Are IL-23 Inhibitors For Psoriasis Treatment? - Psoriasis Relief Guide

What Are

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis

IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis

To cite: Eyerich K, Weisenseel P, Pinter A, et al.

IL-23 Therapies in the Management of Psoriasis: Alice Gottlieb, MD, PhD & April W Armstrong, MD, MPH

IL-23 Therapies in the Management of Psoriasis: Alice Gottlieb, MD, PhD & April W Armstrong, MD, MPH

January 21st, 2020- 2020 Winter Clinical Dermatology Conference – Hawaii.

IL-17 and IL-23 inhibitors in the treatment of psoriatic arthritis

IL-17 and IL-23 inhibitors in the treatment of psoriatic arthritis

Interview with Bruce E. Strober MD, PhD, on

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

The